Infection Control Market Research Report –Global Forecast to 2030

Infection Control Market Research Report Information By Type (Disinfection Products, Sterilization Products and Services, and Others), By End Users (Hospitals and Clinics, Life Sciences Industry, Medical Device Companies, Pharmaceutical Companies, Food Industry, and Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030

ID: MRFR/MED/4445-HCR | 100 Pages | Author: Rahul Gotadki | March 2024         

Infection Control Market Speak to Analyst Request a Free Sample

Global Infection Control Market Overview


Infection Control Market Size was valued at USD 42.2 billion in 2022 and is projected to grow from USD 43.73 Billion in 2023 to USD 54.42 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 3.70% during the forecast period (2023 - 2030). The rising prevalence of hospital-acquired infections and growing awareness regarding cleanliness post-pandemic are the key market drivers enhancing the market growth.
Infection Control Market Overview
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review


Infection Control Market Trends



  • Growing prevalence of hospital-acquired infections (HAIs) to propel the market growth


Millions of patients suffer injuries or deaths yearly due to unsafe and subpar medical care. The burden of harm from inadequate care is significantly increased by numerous medical procedures and risks related to health care. According to World Health Organization, up to 25% of patients experience complications due to unsafe surgical procedures. Every year, nearly 7 million surgical patients experience significant difficulties, and 1 million pass away during or right after surgery. In hospitals in high-income and low- and middle-income countries, healthcare-associated infections affect 7 and 10 out of every 100 patients. Moreover, according to the Centers for Disease Control (CDC), HAIs are thought to be responsible for 1.7 million infections and 99,000 deaths each year. Urinary tract infections make up about 32% of all healthcare-acquired infections, followed by surgical site infections (22%), pneumonia (15%), and bloodstream infections (14%). The growing rate of infections in hospitals has fueled the need for infection control products and boosted market growth.


The various countries' governments are also taking measures to prevent the spread of infection. They are conducting programs or investing to help hospitals control the spread of infections that can harm patients. For instance, in February 2009, President Obama signed Public Law 111-5 (ARRA), also known as the American Recovery and Reinvestment Act of 2009. The Recovery Act authorized USD 50 million to assist states in preventing and reducing infections related to healthcare. Many of these funds support the initiatives listed in the HHS Action Plan to Prevent Health Care-Associated Infections. The Recovery Act site also tracks the efforts made by the states to achieve the plan's objectives. Similarly, Cambridge Health Alliance implemented a 15-month safety improvement programme, sponsored by the Agency for Healthcare Research & Quality, to lower infections in the ICU at its Cambridge and Everett hospitals. Urinary tract infections and central line-associated bloodstream infections significantly decreased due to the effort, which also included assessing potential issues, increased staff education, using tried-and-true best practices, leadership buy-in, and more (CLABSI). Such initiatives are anticipated to positively impact the Infection Control market CAGR across the globe in the coming years.


Moreover, covid-19 pandemic has boosted market growth because hospitals, clinics, pharmaceuticals, and medical device firms now have higher demands for sterilization and disinfection. Additionally, the production of sanitizer products increased by 60% during the pandemic in the United States alone. This demonstrates the growth potential for infection control products in the upcoming years. The introduction of cutting-edge sterilizing solutions and a rise in the outsourcing of sterilization services are among the other factors driving the growth of the Infection Control market revenue.


Infection Control Type Insights


The global Infection Control market segmentation, based on type, includes disinfection products, sterilization products and services, and others. The sterilization products and services segment dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period 2022-2030. The primary factors propelling the market growth are the growing need to reduce hospital-acquired infections and the extensive use of sterilization equipment in healthcare settings. Additionally, the market is expected to grow over the forecast period due to rising surgical rates, an increase in the prevalence of infectious diseases, and expansion in the healthcare sector.


March 2022:Datasea Inc. introduced Ultrasonic Sound Sterilization and Antivirus Equipment aimed at various application scenarios, and it intended to enter the US market with acoustic intelligence products.


May 2020:ATS ELGi introduced a new line of vehicle sterilization products. The Ozone Air Sterilizer uses ozone (a natural form of activated oxygen) to kill bacteria, viruses, molds, allergens, odors, and harmful pollutants like volatile organic compounds (VOCs), ensuring a clean and safe environment inside small passenger cars, sedans, SUVs, commercial vehicles, SCV/LCV/HCV driver cabins, and even ambulances.


Infection Control End User Insights


Based on End Users, the global Infection Control market segmentation has been divided into hospitals and clinics, life sciences industry, medical device companies, pharmaceutical companies, food industry, and others. The hospitals and clinics segment is anticipated to hold the largest market share and grow at a significant CAGR during the coming years. The significant market share is primarily due to the increased risk of contracting infections on hospital grounds through the transmission of respiratory or bloodborne pathogens. HAIs are one of the main problems, so strict control is needed. The need for highly effective control systems has prompted hospitals and public health organizations to adopt them. Additionally, there has been a rise in the use of infection control products due to the rising number of COVID-19 patients and strict regulations put in place by the various governments to combat infections. The life sciences industry is anticipated to grow with the fastest CAGR during the forecast period owing to increasing R&D activities for developing new medicines and vaccines.


Figure 1: Infection Control Market, by End Users, 2022 & 2030 (USD billion)
Infection Control Market, by End Users, 2022 & 2030
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review


Infection Control Regional Insights


By Region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. North America Infection Control market accounted for USD 19.3 billion in 2022 and is expected to exhibit a noteworthy CAGR growth during the study period. A well-developed healthcare infrastructure, widespread use of infection control technologies, and the presence of major market players in the area are some significant drivers of market growth. In addition, recent product launches and government infection control initiatives contribute to the market's expansion.


Further, the major countries studied in the market report are: The U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.


Figure 3: INFECTION CONTROL MARKET SHARE BY REGION 2022 (%)
INFECTION CONTROL MARKET SHARE BY REGION 2022
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review


Europe Infection Control market accounts for the second-largest market share in 2022. Growing government attention to the healthcare industry, an increase in the prevalence of chronic diseases, the COVID-19 pandemic, government funding for the expansion of healthcare facilities, and favorable regulatory reforms are all contributing to the market's growth. Further, the Germany Infection Control market held the largest market share, and the UK Infection Control market was the fastest-growing market in the European region.


The Asia-Pacific Infection Control Market is anticipated to grow at the fastest CAGR from 2022 to 2030. An increase in outsourcing companies, a rise in healthcare spending, and an unprecedented region-wide transformation of healthcare infrastructure and standards are driving the market. One of the key factors influencing the expansion of the Asia Pacific region is the existence of numerous nonprofit and governmental organizations dedicated to raising infection control standards. Moreover, China Infection Control market held the largest market share, and the India Infection Control market was the fastest-growing market in the Asia-Pacific region.


Infection Control Key Market Players & Competitive Insights


Major market players are investing in new products, which is expected to help the Infection Control market grow in the coming years. Companies in the market are also taking various initiatives to expand their worldwide footprint, with key market developments such as new product launches, agreements, increased investments, and collaboration with other companies. Competitors in the Infection Control industry must offer low-cost products to maintain their position in the market.


Major players are adopting strategies such as collaborating with other manufacturers in the global Infection Control industry to expand their presence. Recently, the Infection Control industry has launched some new products to meet the rising demand. The Infection Control markets major player such as STERIS Corporation (U.K.), Getinge Group (Sweden), Cantel Medical Corporation (U.S.), Ecolab (U.S.), 3M Healthcare Company (U.S.), Sotera Health (U.S.), Advanced Sterilization Products (U.S.), MMM Group (Germany), Matachana (Spain), and others are working to introduce new tiles and expanding the market demand by investing in R&D activities.


Advanced Sterilization Products Advanced Sterilization Products (ASP) provide infection prevention solutions for healthcare. The company offers cutting-edge medical sterilization and disinfection products, technologies, and workflows. In August 2021, Advanced Sterilization Products (ASP) announced that the STERRAD VELOCITY Biological Indicator (BI)/Process Challenge Device (PCD) would have a 15-minute time to result and be commercially available in the Asia Pacific region starting on August 25, 2021.


STERIS Life Sciences is a global leader in offering the industries of sterilization, cleaning, and infection control products. In September 2021, STERIS introduced the next generation of integrated Vaporized Hydrogen Peroxide (VHP) bio-decontamination systems for clients seeking to reduce bioburden in GMP pharmaceutical, medical device, and research environments by up to 6-logs. The new VHP 100i and 1000i can run a decontamination cycle at predetermined intervals or in response to a button press. They are made to be integrated into a facility's building automation and HVAC systems. As a result, decontamination of rooms, isolators, filling lines, RABs, pass-through chambers, and other areas is made simple and frequent.


Key Companies in the Infection Control market include



  • STERIS Corporation (U.K.)

  • Getinge Group (Sweden)

  • Cantel Medical Corporation (U.S.)

  • Ecolab (U.S.)

  • 3M Healthcare Company (U.S.)

  • Sotera Health (U.S.)

  • Advanced Sterilization Products (U.S.)

  • MMM Group (Germany)

  • Matachana (Spain), among others


Infection Control Industry Developments


January 2023:W&H, Windsor, introduced the Lexa Plus sterilizer, a pre-vacuum, Class B sterilizer that offers increased capacity, energy-saving fast cycles, automatic water filling, connectivity, and options for traceability.


September 2019:STERIS Corporation introduced Spor-Klenz Ready to Use Disinfectant Wipes for cleanroom disinfectant applications. The Spor-Klenz Ready to Use Disinfectant Wipes utilize a cutting-edge system that combines woven polyester wipes with a unique internal pouch containing the Spor-Klenz Ready to Use formula. In addition to providing a quick, easy, and reliable way to saturate the wipes, the internal pouch enables maximum chemical stability.


Infection Control Market Segmentation


Infection Control Type Outlook



  • Disinfection Products

  • Sterilization Products and Services

  • Others


Infection Control End User Outlook



  • Hospitals and Clinics

  • Life Sciences Industry

  • Medical Device Companies

  • Pharmaceutical Companies

  • Food Industry

  • Others


Infection Control Regional Outlook




  • North America



    • US

    • Canada




  • Europe



    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe




  • Asia-Pacific



    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Australia

    • Rest of Asia-Pacific




  • Rest of the World




    • Middle East




    • Africa




    • Latin America





Report Scope:

Report Attribute/Metric Details
Market Size 2022 USD 42.2 billion
Market Size 2023 USD 43.73 billion
Market Size 2030 USD 54.42 billion
Compound Annual Growth Rate (CAGR) 3.70% (2023-2030)
Base Year 2022
Market Forecast Period 2023-2030
Historical Data 2018 - 2021
Market Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
Segments Covered Type, End User, and Region
Geographies Covered North America, Europe, Asia Pacific, and Rest of the World
Countries Covered The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
Key Companies Profiled STERIS Corporation (U.K.), Getinge Group (Sweden), Cantel Medical Corporation (U.S.), Ecolab (U.S.), 3M Healthcare Company (U.S.), Sotera Health (U.S.), Advanced Sterilization Products (U.S.), MMM Group (Germany), Matachana (Spain)
Key Market Opportunities Growing number of surgical procedures
Key Market Dynamics Covid-19 pandemic Rising prevalence of HAIs Growing government initiatives




Frequently Asked Questions (FAQ) :

The global Infection Control market size was valued at USD 42.2 Billion in 2022.

The global market is projected to grow at a CAGR of 3.70% during the forecast period, 2023-2030.

North America had the largest share of the global market

The key players in the market are STERIS Corporation (U.K.), Getinge Group (Sweden), Cantel Medical Corporation (U.S.), Ecolab (U.S.), 3M Healthcare Company (U.S.), Sotera Health (U.S.), Advanced Sterilization Products (U.S.), MMM Group (Germany), Matachana (Spain), and Others.

The sterilization products and services category dominated the market in 2022.

The hospitals and clinics had the largest share of the global market.

Key Questions Answered

  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Request Free Sample

Why Choose Market Research Future?

  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Speak to Analyst
Leading companies partner with us for data-driven Insights.
Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response
Invalid